Pfizer Inc.
CL ˙ SNSE ˙ US7170811035
SecurityCL:PFE / Pfizer Inc.
InstitutionOarsman Capital, Inc.
Latest Disclosed Ownership24,020 shares
Latest Disclosed Value $ 674,471
Oarsman Capital, Inc. reports 21.68% decrease in ownership of PFE / Pfizer Inc.

On April 27, 2026 - Oarsman Capital, Inc. filed a 13F-HR form disclosing ownership of 24,020 shares of Pfizer Inc. (CL:PFE) valued at $674,471 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 30,670 shares of Pfizer Inc.. This represents a change in shares of -21.68% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F PFIZER INC COM Stock 717081103 24,020 -6,650 -21.68 674 -11.66 0.0837
2026-02-13 2025-12-31 13F PFIZER INC COM Stock 717081103 30,670 -1,047 -3.30 764 -5.57 0.0991
2025-11-21 2025-09-30 13F PFIZER INC COM Stock 717081103 31,717 -1,865 -5.55 808 -0.74 0.1133
2025-08-01 2025-06-30 13F PFIZER INC COM Stock 717081103 33,582 -1,022 -2.95 814 -7.08 0.1276
2025-05-14 2025-03-31 13F PFIZER INC COM Stock 717081103 34,604 1,035 3.08 877 -1.57 0.1575
2025-02-13 2024-12-31 13F PFIZER INC COM Stock 717081103 33,569 -959 -2.78 891 -10.91 0.1551
2024-11-08 2024-09-30 13F PFIZER INC COM Stock 717081103 34,528 296 0.86 999 4.39 0.1840
2024-08-12 2024-06-30 13F PFIZER INC COM Stock 717081103 34,232 120 0.35 958 1.16 0.2097
2024-05-15 2024-03-31 13F PFIZER INC COM Stock 717081103 34,112 20,567 151.84 947 143.19 0.2261
2024-02-16 2023-12-31 13F PFIZER INC COM Stock 717081103 13,545 -966 -6.66 390 -19.13 0.1035
2023-10-27 2023-09-30 13F PFIZER INC COM Stock 717081103 14,511 2,170 17.58 481 6.42 0.2011
2023-08-10 2023-06-30 13F PFIZER INC COM Stock 717081103 12,341 -1,001 -7.50 453 -16.91 0.1982
2023-05-11 2023-03-31 13F PFIZER INC COM Stock 717081103 13,342 -341 -2.49 544 -22.40 0.2544
2023-02-09 2022-12-31 13F PFIZER INC COM Stock 717081103 13,683 -1,925 -12.33 701 2.64 0.3579
2022-11-10 2022-09-30 13F PFIZER INC COM Stock 717081103 15,608 1,208 8.39 683 -9.54 0.3660
2022-08-10 2022-06-30 13F Pfizer COM 717081103 14,400 -2,446 -14.52 755 -13.42 0.3749
2022-05-11 2022-03-31 13F Pfizer COM 717081103 16,846 -4,809 -22.21 872 -31.82 0.3406
2022-02-10 2021-12-31 13F Pfizer COM 717081103 21,655 -2,679 -11.01 1,279 22.16 0.5042
2021-11-12 2021-09-30 13F Pfizer COM 717081103 24,334 -1,986 -7.55 1,047 1.55 0.4238
2021-08-12 2021-06-30 13F Pfizer COM 717081103 26,320 234 0.90 1,031 9.10 0.4096
2021-05-12 2021-03-31 13F Pfizer COM 717081103 26,086 -3,067 -10.52 945 -11.93 0.4089
2021-02-11 2020-12-31 13F Pfizer COM 717081103 29,153 -464 -1.57 1,073 -1.29 0.4169
2020-11-12 2020-09-30 13F Pfizer COM 717081103 29,617 -217 -0.73 1,087 11.37 0.4898
2020-08-13 2020-06-30 13F Pfizer COM 717081103 29,834 5,138 20.80 976 21.09 0.4823
2020-05-13 2020-03-31 13F Pfizer COM 717081103 24,696 -5,647 -18.61 806 -32.21 0.7443
2020-02-13 2019-12-31 13F Pfizer COM 717081103 30,343 145 0.48 1,189 9.59 0.5435
2019-11-12 2019-09-30 13F Pfizer COM 717081103 30,198 -86 -0.28 1,085 -17.30 0.5164
2019-08-13 2019-06-30 13F Pfizer COM 717081103 30,284 -54 -0.18 1,312 1.86 0.5946
2019-05-14 2019-03-31 13F Pfizer COM 717081103 30,338 -672 -2.17 1,288 -4.87 0.6118
2019-02-13 2018-12-31 13F Pfizer COM 717081103 31,010 -1,264 -3.92 1,354 -4.78 0.6939
2018-11-07 2018-09-30 13F Pfizer COM 717081103 32,274 -655 -1.99 1,422 19.00 0.5727
2018-08-10 2018-06-30 13F Pfizer COM 717081103 32,929 -1,425 -4.15 1,195 -1.97 0.5429
2018-05-14 2018-03-31 13F Pfizer COM 717081103 34,354 -1,513 -4.22 1,219 -6.16 0.5549
2018-02-08 2017-12-31 13F Pfizer COM 717081103 35,867 -1,915 -5.07 1,299 -3.71 0.5592
2017-11-13 2017-09-30 13F Pfizer COM 717081103 37,782 -3,116 -7.62 1,349 -1.82 0.5702
2017-08-10 2017-06-30 13F Pfizer COM 717081103 40,898 -852 -2.04 1,374 -3.78 0.6282
2017-05-11 2017-03-31 13F Pfizer COM 717081103 41,750 17,888 74.96 1,428 84.26 0.6646
2017-02-09 2016-12-31 13F Pfizer COM 717081103 23,862 -22,795 -48.86 775 -50.95 0.4990
2016-11-10 2016-09-30 13F Pfizer COM 717081103 46,657 -170 -0.36 1,580 -4.18 0.8058
2016-08-12 2016-06-30 13F Pfizer COM 717081103 46,827 -564 -1.19 1,649 17.37 0.8571
2016-05-12 2016-03-31 13F Pfizer COM 717081103 47,391 -1,355 -2.78 1,405 -10.74 0.7472
2016-02-11 2015-12-31 13F Pfizer COM 717081103 48,746 -1,747 -3.46 1,574 -0.76 0.8809
2015-11-10 2015-09-30 13F Pfizer COM 717081103 50,493 -355 -0.70 1,586 -6.98 0.9373
2015-08-13 2015-06-30 13F Pfizer COM 717081103 50,848 505 1.00 1,705 -2.63 1.1628
2015-05-14 2015-03-31 13F Pfizer COM 717081103 50,343 134 0.27 1,751 11.96 1.2093
2015-02-06 2014-12-31 13F Pfizer COM 717081103 50,209 -1,491 -2.88 1,564 2.29 1.1272
2014-11-06 2014-09-30 13F Pfizer COM 717081103 51,700 -1,240 -2.34 1,529 -2.67 1.1271
2014-08-08 2014-06-30 13F Pfizer COM 717081103 52,940 3,280 6.60 1,571 -1.50 1.1397
2014-04-25 2014-03-31 13F Pfizer COM 717081103 49,660 -395 -0.79 1,595 4.04 1.2312
2014-02-06 2013-12-31 13F Pfizer COM 717081103 50,055 -95 -0.19 1,533 6.38 1.2308
2013-11-13 2013-09-30 13F Pfizer COM 717081103 50,150 1,280 2.62 1,441 5.26 1.2581
2013-08-08 2013-06-30 13F Pfizer COM 717081103 48,870 48,870 1,369 1.2954
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.